Photo: Eisai website
Eisai follows family ties with name for newly approved Alzheimer's drug Leqembi
The road to approval for Alzheimer’s drug Leqembi began more than a decade ago when Eisai and Biogen collaborated on a first trial for what …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
